TOFACITINIB IN ULCERATIVE COLITIS: REAL WORLD EVIDENCE (To-ReWard Study)
INDEPENDENT POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: PEREZ GISBERT, JAVIER
- Execution start: 24/06/2021
- End of execution: 30/03/2022
- IP: MARIA JOSE CABELLO TAPIA